R&D Podcasts | pharmaphorum

Podcasts

R&D

Challenges and opportunities in synthetic clinical trials

Of the many changes coming to clinical trials, one of the biggest potential paradigm shifts on the horizon is the elimination of placebo groups in some trials in favour of synthetic control

R&D

pharmaphorum podcast episode 132a - woman on her phone listening to headphones

In vitro gametogenesis: the science has to be right, and it ...

In vitro gametogenesis (IVG) holds much potential for same-sex couples and women of a more advanced age struggling with infertility, but the question is whether we’re quite there yet.

R&D

Proving ROI for digital endpoints

The costs associated with clinical trials are a major bottleneck to drug development and affordability.

R&D

Is precision psychiatry possible?

Anyone who has taken a psychiatric medication knows that the status quo in prescribing is a trial and error approach, with patients often cycling through an array of drugs to find the one t

R&D

Harnessing the velocity of biopharmaceutical advances

Today’s pharmaphorum podcast addresses the subject of speed – the velocity at which biopharma is bringing new therapies and medicines to market faster.

R&D